Functional Genomic Approaches to Identify Key Regulators of Human Tregs

Time: 2:00 pm
day: Day Two


  • Utilizing CRISPR-based functional genomics to harness the therapeutic potential of human Tregs for autoimmunity
  • Overview of in vitro and in vivo systems to identify and validate Treg target
  • Examples of therapeutic applications for Treg targets (e.g., small molecule, large molecule, and cellular therapy approaches